This program will describe hepatocellular carcinoma screening and surveillance in patients with chronic hepatitis B, utilizing our current available biomarkers and applying those to scoring systems as well as providing imaging updates. Register today: aasld.org/webinar-update…

Hepatocellular carcinoma screening is associated with reduced mortality even after accounting for lead-time & length-time biases, this study finds. ja.ma/3JEUDCM Amit G Singal Darine Daher Neehar Parikh @drhuangdq Nicole Rich @kanwalfasiha anand kulkarni @bluefaeryliver

British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults ⁦Gut Journal⁩ gut.bmj.com/content/early/…

Interesting technique for treating buried bumper syndrome from #ESGEDays2024

1/4
📣Pilot OPEN LABEL randomized trial

🔥1 vs 3 days of terli for variceal bleeding
🔥no difference in re🩸 and death

What are the main problems of OPEN LABEL trials? 🧵👇

onlinelibrary.wiley.com/doi/full/10.11…

#livertwitter Manas Vaishnav roypounder.apt

Elliot Tapper great thought: paths after #decomensation
😫 further decompensate: t.ly/4-nGZ
🙃 control symptoms by etiolologic ther
🛑🍻alcohol abstinence t.ly/o0Qxd
🛑🎊viral eradication t.ly/uXV46
✅ fully recompensate (Alb, INR) t.ly/7Y4T5

Online now in GIE’s Articles in Press: “Comparing a 19-gauge fine-needle biopsy needle with a 22-gauge fine-needle biopsy needle for EUS-guided liver biopsy sampling: a prospective randomized study' by David L. Diehl et al. giejournal.org/article/S0016-…

David Diehl

If you missed it, don't worry! Here is the recorded webinar:
oaepublish.com/webinars/mtod.…
#LiverTwitter #MASLD #MetALD #ALD

Is Ursodeoxycholic Acid (UDCA) useful for drug-induced liver disease?

This great review by Fernando Bessone et al. reviews its mechanisms of action and clinical usefulness in Seminars in Liver Disease.
shorturl.at/bmE69

📑 The #GAAD algorithm is an in vitro diagnostic combining PIVKA-II and AFP, age and sex at birth, that significantly ⬆️ #HCC detection irrespective of disease stage, etiology or 🌍 region❕
#LiverTwitter

journals.lww.com/hepcomm/fullte…

A comprehensive review on immune-related adverse effects during Tx of advanced #HCC
🔻Commonly reported types of irAEs
🔻Specific irAEs associated with each ICI agent
🔻Rare but potentially fatal irAEs
🔻Available Tx options for managing irAEs

👉doi.org/10.17998/jlc.2…

Important study in #HCC detection
🟢Biannual US -> suboptimal performance for early-stage
🔵Annual NC-AMRI ⬆️ diagnostic yield without⬆️ false referral
🔴Alternating biannual US & NC-AMRI⬆️ sensitivity>> biannual US
#livertwitter
Journal of Hepatology
journal-of-hepatology.eu/article/S0168-…

REVIEW
Noninvasive assessment of hepatic decompensation
Maja Thiele et al.
#LiverTwitter
tinyurl.com/2ykcdxhk

🧑‍💼Liver disease is a leading cause of years of working life lost.

🤔Did you know that it ranks second only to ischaemic heart disease in causing years of working life lost in Europe?

It's time for a fundamental change to focus on early identification and prevention…

AFRI-SWE for cACLD setting:

✅SWE has prognostic value, but ‼️ cutoff is DIFFERENT from VCTE

👉youtu.be/yqlfhEXoQSQ

#Livertwitter Thomas Reiberger Annalisa Berzigotti Juan G Abraldes Elliot Tapper

GBD DALY ⁦Data The Lancet⁩
COVID-19 🏆
AUD @ 22 among top 25 YLD
Cirrhosis & AUD among top 10 in European countries.
IHD,Neonatal 🦠& stroke continue!
⁦Ramon Bataller⁩ ⁦⁦EASL Education⁩ ⁦Peter Jepsen⁩ European Liver Patients' Association⁩ ⁦ #livertwitter thelancet.com/journals/lance…

🍺❌EASL's recommendations for reducing alcohol harms align with the spirit of #WorldLiverDay .

We must prioritise public health over profit and protect our communities from harmful alcohol consumption.

💰🔞We advocate for evidence-based policies, from minimum unit pricing to…

On #WorldLiverDay , read Journal of Hepatology’s latest Editor’s Choice Collection to discover some influential research recently published in the journal: spkl.io/60134F2Gz

EASLnews EASL Education

JUST OUT in time for #WorldLiverDay
'Use of non-invasive diagnostic tools for metabolic dysfunction-associated steatohepatitis: A qualitative exploration of challenges and barriers'
onlinelibrary.wiley.com/doi/10.1111/li…
#LiverTwitter

Liver cancer cases have doubled in Europe over the past 30 years, with chronic liver disease as a major risk factor. Today, on #WorldLiverDay , we call for screening, prevention, and access to care to combat this growing health challenge.

👉Read the policy statement:…